Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PhRMA In The Game: Tauzin Pitches Universal Rx Coverage At Health Summit

Executive Summary

Pharmaceutical Research and Manufacturers of America President Billy Tauzin got the opportunity to make a case for universal drug coverage to some key congressional and administration players at the White House forum on health reform March 5

You may also be interested in...



PhRMA Targets High Cost-Sharing For Drugs In Comments To CMS

The Pharmaceutical Research and Manufacturers of America is highlighting the negative impact high cost-sharing can have on patient access to drugs, most recently in comments on the draft 2010 "call letter" for Part D plans

PhRMA Targets High Cost-Sharing For Drugs In Comments To CMS

The Pharmaceutical Research and Manufacturers of America is highlighting the negative impact high cost-sharing can have on patient access to drugs, most recently in comments on the draft 2010 "call letter" for Part D plans

The 1% Solution To Health Care Reform: AHIP’s Ignagni Urges All Stakeholders To Trim Growth

National Journal panelists agree there will be up-or-down vote on universal coverage this year, but public plan option is stumbling block.

Related Content

Topics

UsernamePublicRestriction

Register

MT003605

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel